These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 2252337)

  • 21. On serotonin and migraine: a clinical and pharmacological review.
    Ferrari MD; Saxena PR
    Cephalalgia; 1993 Jun; 13(3):151-65. PubMed ID: 8395342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Noci-autonomic-affective automatism, the physiopathological essence of hemicrania. The serotonin theory as a guiding principle in the labyrinth of interpretations].
    Nicolodi M; Sicuteri F; Sicuteri R
    Ann Ital Med Int; 1992; 7(3 Suppl):7S-22S. PubMed ID: 1297400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of sumatriptan in the treatment of migraine.
    Gross M
    Br J Clin Pract; 1993; 47(4):205-7. PubMed ID: 8260340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of serotonin and other neuroactive molecules in the physiopathogenesis of migraine. Current hypotheses].
    Hamon M; Bourgoin S
    Pathol Biol (Paris); 2000 Sep; 48(7):619-29. PubMed ID: 11072640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sumatriptan for the treatment of undifferentiated primary headaches in the ED.
    Miner JR; Smith SW; Moore J; Biros M
    Am J Emerg Med; 2007 Jan; 25(1):60-4. PubMed ID: 17157685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current concepts of the pathophysiology of migraine.
    Goadsby PJ
    Neurol Clin; 1997 Feb; 15(1):27-42. PubMed ID: 9058395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of 5HT in migraine.
    Buzzi MG
    Cephalalgia; 1999 Sep; 19(7):625-6. PubMed ID: 10524654
    [No Abstract]   [Full Text] [Related]  

  • 28. The discovery of a new drug class for the acute treatment of migraine.
    Humphrey PP
    Headache; 2007 Apr; 47 Suppl 1():S10-9. PubMed ID: 17425704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Function of the peripheral serotoninergic pathways in migraine: a proposal for an experimental model.
    Martelletti P; Stirparo G; Rinaldi C; Fusco BM
    Cephalalgia; 1994 Feb; 14(1):11-5; discussion 4. PubMed ID: 7515328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sumatriptan: a new drug for vascular headache.
    Hsu VD
    Clin Pharm; 1992 Nov; 11(11):919-29. PubMed ID: 1334452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy.
    Villalón CM; Centurión D; Valdivia LF; De Vries P; Saxena PR
    Proc West Pharmacol Soc; 2002; 45():199-210. PubMed ID: 12434581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications.
    Villalón CM; Centurión D
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Oct; 376(1-2):45-63. PubMed ID: 17703282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Journey of the Non-Vascular Relief for Migraine: From 'Triptans' To 'Ditans'.
    Xavier AS; Lakshmanan M; Gunaseelan V
    Curr Clin Pharmacol; 2017; 12(1):36-40. PubMed ID: 28425871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurogenic vs vascular mechanisms of sumatriptan and ergot alkaloids in migraine.
    Edvinsson L
    Cephalalgia; 1998 Jan; 18(1):5. PubMed ID: 9601617
    [No Abstract]   [Full Text] [Related]  

  • 35. 5-Hydroxytryptamine receptor subtypes and the pharmacology of migraine.
    Peroutka SJ
    Neurology; 1993 Jun; 43(6 Suppl 3):S34-8. PubMed ID: 8389009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serotonin agonists and antagonists in migraine].
    Ollat H
    Pathol Biol (Paris); 1992 Apr; 40(4):389-96. PubMed ID: 1353874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin receptor targeted therapy for migraine treatment: an overview of drugs in phase I and II clinical development.
    Barbanti P; Aurilia C; Egeo G; Fofi L; Palmirotta R
    Expert Opin Investig Drugs; 2017 Mar; 26(3):269-277. PubMed ID: 28103158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A
    Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The search for novel migraine therapies: experimental models.
    Parsons AA; Bingham S
    Funct Neurol; 2000; 15 Suppl 3():36-42. PubMed ID: 11200799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical profile of sumatriptan: efficacy in migraine.
    Pilgrim AJ
    Eur Neurol; 1994; 34 Suppl 2():26-34. PubMed ID: 7835380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.